Current Report Filing (8-k)
May 05 2021 - 4:11PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 5, 2021
INOTIV, INC.
|
(Exact name of registrant as specified in its charter)
|
Indiana
|
|
0-23357
|
|
35-1345024
|
(State or other jurisdiction of incorporation or organization)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
2701 KENT AVENUE
WEST LAFAYETTE, INDIANA
|
|
47906-1382
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant's telephone number, including area code:
(765) 463-4527
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to
Rule 14a-12 under the Exchange Act(17CFR240.14a-12)
|
|
¨
|
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act(17CFR240.14d-2(b))
|
|
¨
|
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act(17CFR240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act
|
|
Name of each exchange
|
Title of each class
|
Trading Symbol(s)
|
on which registered
|
Common Shares
|
NOTV
|
NASDAQ Capital Market
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ¨
The information provided in Item 2.02 and Item
9.01 of this Form 8-K is being furnished and shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 and Item 9.01 of this Form
8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as
amended.
Item 2.02. Results
of Operations and Financial Condition.
On May 5, 2021, Inotiv, Inc.
issued a press release announcing financial results for the three and six months of fiscal 2021 ended March 31, 2021. The full text of
the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Item 9.01. Financial
Statements and Exhibits.
(a) Not
applicable.
(b) Not
applicable.
(c) Not
applicable.
(d) Exhibits
99.1 Inotiv, Inc. press release, issued May 5, 2021.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
INOTIV, Inc.
|
|
|
|
|
|
|
|
|
Date: May 5, 2021
|
By:
|
/s/ Beth A. Taylor
|
|
|
|
Chief Financial Officer,
|
|
|
|
Vice President—Finance
|
|
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Apr 2023 to Apr 2024